APN News

  • Wednesday, May, 2024| Today's Market | Current Time: 07:41:34
  • $150,000 Worth of Scholarships Awarded at Leverage Edu’s Study Abroad Fair & Roadshow in Ryan Group of Institutions

    Published on December 15, 2023

     New Delhi: Study Abroad Major, Leverage Edu, today announced the conclusion of its 7-city roadshow in collaboration with India’s prominent K-12 institution – Ryan Group Schools. Focused on promoting undergraduate studies abroad, it was conducted across Chandigarh, Ludhiana, Amritsar, Greater Noida, Delhi, Bangalore & Mumbai.

    The biggest Study Abroad event of 2023 witnessed participation from more than 120 universities across the UK, the US, Dubai, Australia, and Canada. All 7 cities have seen a combined footfall of over 7,000 students and parents.

    “I met Ryan sometime last year and was immediately drawn towards his ideas and commitment for students to thrive in this constantly shifting new world. He not only vocalizes it, but that impact is reflected in the quality of education his group’s schools are leading with. Personally, I am super pumped about this partnership. The response towards the fairs has been huge, and the universities we brought onboard have been very impressed, so it’s a win-win for everyone!” said Akshay Chaturvedi, Founder & CEO of Leverage.biz, which operates flagship brands Leverage Edu, Fly Finance, and Fly Homes.

    Mr. Ryan Pinto, CEO of Ryan Group of Institutions, shared, “The Study Abroad Fair and Roadshow transcend mere events; they serve as gateways for students to delve into international academic excellence. It’s more than an occasion; it’s a compelling opportunity to inspire and guide them toward shaping a globally competitive future. I wholeheartedly endorse Akshay’s mission to democratize access to quality education and truly believe in their vision. May this unique event and partnership kindle the aspirations of India’s school students, urging them to embrace a global education that goes beyond our conventional choices.”

    SEE COMMENTS

    Leave a Reply